Kevin C. Welch

Kevin C. Welch

Auto-generated profile, based on publicly available information

Kevin C. Welch

Northwestern University Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
NINaruhito Iwasaki
Naruhito Iwasaki
JPJulie A. Poposki
Julie A. Poposki
AOAiko Oka
Aiko Oka
MKMasanori Kidoguchi
Masanori Kidoguchi
AKAiko I. Klingler
Aiko I. Klingler
AKAtsushi Kato
Atsushi Kato

1 June 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
JKJason H. Kwah
Jason H. Kwah
SSShaan N. Somani
Shaan N. Somani
WSWhitney W. Stevens
Whitney W. Stevens
RKRobert C. Kern
Robert C. Kern
SSStephanie S. Smith
Stephanie S. Smith
APAnju T. Peters
Anju T. Peters
Chronic rhinosinusitis (CRS) is complicated by frequent acute exacerbations leading to significant health care burden and impaired quality of life. The objective of this study was to identify clinical factors associated with frequent acute exacerbation of CRS (AECRS). This is a retrospective cohort study of patients with CRS from January 1, 2014, to May 31, 2016. Frequent AECRS was defined as at least 4 episodes over a 12-month period in which an antibiotic was prescribed for worsening sinus symptoms, and infrequent AECRS was defined as 0 to 3 episodes. Clinical factors, including asthma, allergic rhinitis, eosinophil count of at least 150 cells per microliter, and autoimmune disease, were evaluated for associations between the 2 groups. Of the 3109 patients with CRS who were identified, 600 (19.3%) were classified as having frequent exacerbation. Asthma, allergic rhinitis, eosinophil count of at least 150 cells per microliter, and autoimmune disease were associated with frequent AECRS with statistically significant adjusted odds ratios (aORs) after controlling for age, race, and sex in multivariate analysis (asthma aOR = 2.61 [95% CI = 2.14-3.18]; allergic rhinitis aOR = 1.96 [95% CI = 1.58-2.42]; eosinophil count of at least 150 cells per microliter aOR = 1.54 [95% CI = 1.21-1.97]; and autoimmune disease aOR = 1.68 [95% CI = 1.36-2.07]). Antibody deficiency, antibiotic allergy, lower FEV1, radiographic sinus disease severity, nasal polyposis, and systemic corticosteroid use were also associated with frequent AECRS. Patients with frequent episodes of AECRS were characterized by a higher prevalence of asthma, allergic rhinitis, eosinophil count of at least 150 cells per microliter, autoimmune disease, and other allergic and immunologic diseases. These findings identify a high-risk phenotype of patients with CRS for preventive interventions to reduce exacerbation frequency.

16 March 2021 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
KLKatherine A. Lin
Katherine A. Lin
CPCaroline P.E. Price
Caroline P.E. Price
JHJulia H. Huang
Julia H. Huang
SGSaied Ghadersohi
Saied Ghadersohi
DCDavid Cella
David Cella
BTBruce K. Tan
Bruce K. Tan

31 May 2025 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
MPMarn Joon Park
Marn Joon Park
JFJakob Louis Fischer
Jakob Louis Fischer
VRVijay R. Ramakrishnan
Vijay R. Ramakrishnan
KWKevin C. Welch
Kevin C. Welch
DKDong-Kyu Kim
Dong-Kyu Kim
JSJeffrey D. Suh
Jeffrey D. Suh
The sphenoid sinus presents significant challenges during endoscopic sinus surgery. It is essential that surgeons employ strategies that effectively address sphenoid pathology while minimizing surgical risks and optimizing outcomes. Although nomenclature for maxillary and frontal sinus surgery is well established, there is currently no standardized nomenclature for sphenoid sinus surgery. We present a comprehensive review of techniques for accessing the sphenoid sinus and propose a common surgical classification system to better define and categorize these approaches. Each technique is classified based on surgical extent, anticipated operation time, complexity, potential complications, and expected wound healing, aligning with established standards in the literature. The proposed sphenoidotomy types are as follows: type I, sphenoid ostial dilation; type IIa, transnasal sphenoidotomy (sphenoidotomy without ethmoidectomy); type IIb, transethmoidal sphenoidotomy (sphenoidotomy with ethmoidectomy); type III, bilateral, common cavity sphenoidotomy, or “sphenoid drill-out;” type IV, transpterygoid approach, to expose the lateral sphenoid sinus recess; and type V, sphenoid nasalization, completely removing the sphenoid sinus floor. By standardizing the nomenclature for these techniques, we aim to enhance consistency in terminology for teaching, surgical planning, clinical research, and interdisciplinary communication in sphenoid sinus surgery.

1 February 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SBSumit Bose
Sumit Bose
WSWhitney W. Stevens
Whitney W. Stevens
NLNewton Li
Newton Li
MRMariel G. Rosati
Mariel G. Rosati
LGLeslie C. Grammer
Leslie C. Grammer
APAnju T. Peters
Anju T. Peters

1 October 2015 in Otolaryngologic Clinics of North America
Verified
Journal Article
Closed access
KWKevin C. Welch
Kevin C. Welch